research and development of colloid / surfactant applications (polyelectrolytes, phospholipids, natural waxes and oils) to cosmetics, topical pharmaceuticals, emulsions, microemulsions, liquid crystals, and dispersions. In topical pharmaceuticals, the principal product is the development of SootheXP which was marketed by Bausch & Lomb. This technology was based on research currently incorporated in Systane Balance (Alcon) determination of structure / function of Definity (Bristol-Myers-Squibb) provided insight into native / "activated" forms of the injectible for ultrasonic contrast enhancement of cardiac tissue